載入...
Use of Bevacizumab and Ranibizumab for Wet Age-Related Macular Degeneration: Influence of CATT Results and Introduction of Aflibercept
PURPOSE: To assess whether publication of Comparison of Age-related macular degeneration Treatment Trial (CATT) results and introduction of aflibercept to the marketplace affected intravitreal bevacizumab and ranibizumab utilization. DESIGN: Retrospective analysis of treatment patterns. METHODS: We...
Na minha lista:
| 發表在: | Am J Ophthalmol |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6856411/ https://ncbi.nlm.nih.gov/pubmed/31100217 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajo.2019.05.011 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|